G protein-coupled receptors in neurodegenerative diseases and psychiatric disorders | Signal Transduction and Targeted Therapy
Prescription Drug Abuse - ppt download
Atomoxetine and circadian gene expression in human dermal fibroblasts from study participants with a diagnosis of attention-deficit hyperactivity disorder | SpringerLink
Characteristics of the inhibitory effects of atomoxetine and reboxetine... | Download Scientific Diagram
Atomoxetine, ADHD, and the ongoing debate about increased risk of suicidal behaviors: the understudied role of kappa opioid rece
Kappa Opiate Receptor Agonist - an overview | ScienceDirect Topics
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
G protein-coupled receptors in neurodegenerative diseases and psychiatric disorders | Signal Transduction and Targeted Therapy
Mixed Kappa/Mu Partial Opioid Agonists as Potential Treatments for Cocaine Dependence - ScienceDirect
ATOMOXETINE HYDROCHLORIDE
Catecholamines Alter the Intrinsic Variability of Cortical Population Activity and Perception | bioRxiv
Warning: Atomoxetine may increase suicidal feelings by activating the Kappa Opioid receptor : r/ADHD
Atomoxetine - Wikipedia
Molecular Characterisation of the Mechanism of Action of Stimulant Drugs Lisdexamfetamine and Methylphenidate on ADHD Neurobiology: A Review | SpringerLink
Antioxidants | Free Full-Text | Inflaming the Brain with Iron
A Narrative Pharmacological Review of Buprenorphine: A Unique Opioid for the Treatment of Chronic Pain | SpringerLink
A review of the abuse potential assessment of atomoxetine: a nonstimulant medication for attention-deficit/hyperactivity disorder - Document - Gale OneFile: Health and Medicine
Machine Learning Analysis of Cocaine Addiction Informed by DAT, SERT, and NET-Based Interactome Networks | Journal of Chemical Theory and Computation
Mixed Kappa/Mu Partial Opioid Agonists as Potential Treatments for Cocaine Dependence - ScienceDirect
Atomoxetine and circadian gene expression in human dermal fibroblasts from study participants with a diagnosis of attention-deficit hyperactivity disorder | SpringerLink
US10316021B2 - Heteroarylphenoxy benzamide kappa opioid ligands - Google Patents
Molecular Characterisation of the Mechanism of Action of Stimulant Drugs Lisdexamfetamine and Methylphenidate on ADHD Neurobiology: A Review | SpringerLink
